Distinguished Academician Exposes the ‘Hidden Toll’ of Topical Steroid Abuse (TSDF), Demanding Immediate Global Policy Intervention and Stricter Regulatory Controls
Apollo Kolkata Senior Consultant Honored with ‘Pioneering Force in Skincare Innovation 2026’ Award for Decades of Clinical Advocacy Against Unregulated Skin Creams
At the landmark 17th Annual Healthcare Leadership Summit & Power Brand Awards, held at the Hotel Mumbai International Airport, the global medical fraternity turned its focus toward an escalating crisis in dermatology.
Dr. Koushik Lahiri—Adjunct Professor and Distinguished Academician at the Apollo Hospitals Educational and Research Foundation (AHERF), Senior Consultant Dermatologist at Apollo Multispeciality Hospitals, Kolkata, and Honorary Medical Director of WIZDERM—delivered an impassioned, groundbreaking keynote address confronting the devastating impacts of unregulated steroid misuse.
His presentation, titled “Faces of Damage — The Hidden Toll of Topical Steroid Dependence: TSDF: A Global Dermatology Challenge Demanding Action,” served as a stark wake-up call to healthcare executives, innovators, and policymakers attending the summit, themed “Reimagining Healthcare – Powering Trust, Innovation & Global Impact.”
Unmasking a Silent, Global Epidemic
Dr. Lahiri, who pioneered the medical terminology Topical Steroid-Damaged/Dependent Face (TSDF) in 2008, used the high-profile platform to outline how a vital class of pharmaceuticals has transformed into a major public health hazard through irrational, indiscriminate, and over-the-counter (OTC) misuse.
“This is an entity of true cutaneous pharmacodependence,” Dr. Lahiri emphasized during his address. “What begins as an unsupervised attempt to self-treat minor acne, melasma, or even to seek cosmetic skin-lightening results in severe, semi-permanent, or permanent physical damage, accompanied by profound psychological addiction.”
Dr. Lahiri detailed the classic clinical manifestations of TSDF, including:
- Severe epidermal atrophy (skin thinning)
- Diffuse facial erythema (persistent redness) and telangiectasia (visible, broken blood vessels)
- Monomorphic acneiform eruptions and steroid-induced rosacea
- Extreme rebound flares upon attempting to discontinue the cream, trapping patients in a vicious cycle of dependency.
A Call for Global Regulatory and Clinical Restructuring
The presentation underscored that TSDF is no longer just a regional problem but a global dermatology challenge that cuts across demographics, aggressively impacting young adults and vulnerable populations unaware of the long-term toxicity of potent topical corticosteroids.
Dr. Lahiri urged a multi-pronged strategy to combat the crisis, demanding immediate action across three distinct frontiers:
- Stricter Regulatory Oversight: Reclassifying potent topical corticosteroids globally to strictly enforce prescription-only compliance, choking off illegal OTC retail pipelines and misleading cosmetic formulations.
- Medical Fraternity Vigilance: Enhancing education among non-dermatologist prescribers, pharmacies, and general practitioners to prevent irrational compound blending.
- Public Awareness Campaigns: Dismantling the deceptive narrative surrounding “miracle fairness creams” that quietly lace their formulations with high-potency molecules.
The summit, organized by the Network 7 Media Group’s healthcare vertical Pharma Leaders, concluded its evening by honoring the pioneers driving modern medicine. Acknowledging his decades of relentless advocacy, global research, and clinical leadership in tackling this epidemic, Dr. Koushik Lahiri was presented with the Pioneering Force in Skincare Innovation 2026 award.
This broadcast covers the highlights and major addresses from the elite healthcare summit where global medical challenges and pioneering innovations were brought to the forefront.
“The Face of Medicine is Compromised When Miracles are Sold Over the Counter.”
Dr. Satya Brahma Demands Aggressive Global Regulation to Halt the Epidemic of Steroid-Induced Facial Damage
We cannot build a future of trusted healthcare when potent pharmaceuticals are masquerading as cosmetic shortcuts. The silent epidemic of Topical Steroid-Damaged Face (TSDF) is not just a clinical failure; it is a regulatory crisis that demands immediate, fearless intervention said Dr. Satya Brahma, Chairman, Network 7 Media Group
